Recombigen Laboratories Private Limited, a active private limited company, was established on 07 January 1999 in Delhi, Delhi, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U24231DL1999PTC097838. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹5.11 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Radhika Beri (Director), Rajesh Beri (Director). Past directors included Radhika Beri, Rishu Beri, Sunil Dutt Sethi. It holds ₹9.69 Cr open charges and ₹1.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Prop. No. 98, Phase-Ii Badli Industrial Estate, Delhi, Delhi, 110042.
U24231DL1999PTC097838
097838
07 January 1999
₹1.25 Cr
₹5.11 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Recombigen Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Radhika Beri | Director | 20 Apr 2022 | Current |
| Rajesh Beri | Director | 07 Jan 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Apr 2019 | Past |
| Pramod Abcsdd | Director | 04 Jun 2025 | Past |
| Pramod Abcsdd | Director | 10 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Recombigen Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.94% increase. The company also saw a slight improvement in profitability, with a 7.26% increase in profit. The company's net worth Soared by an impressive increase of 33.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Recombigen Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹96,935,000.00
₹11,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2022 | Sidbi | ₹8.10 M | Open |
| 30 Jan 2021 | Others | ₹1.75 M | Open |
| 21 Jun 2019 | Axis Bank Limited | ₹1.92 M | Open |
| 21 Jun 2019 | Axis Bank Limited | ₹0.67 M | Open |
| 25 Oct 2017 | Yes Bank Limited | ₹8.45 Cr | Open |
Explore comprehensive loan charge details -
Recombigen Laboratories has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Recombigen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recombigen Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Recombigen Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Recombigen Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on A charge with Yes Bank Limited of Rs. 8.45 Cr registered on 25 Oct 2017 with Charge ID 100161772 was modified on 28 Mar 2025. was documented.
Progress on A charge with Sidbi amounted to Rs. 0.81 Cr with Charge ID 100633406 was registered on 08 Aug 2022. was documented.
Radhika Beri was appointed as a Director was appointed as a Director on 20 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.18 Cr with Charge ID 100447845 was registered on 30 Jan 2021. was completed.
The CIN of Recombigen Laboratories Private Limited is U24231DL1999PTC097838.
Recombigen Laboratories Private Limited is headquartered at Prop. No. 98, Phase-Ii Badli Industrial Estate, Delhi, Delhi, 110042.
Recombigen Laboratories Private Limited was incorporated on 07 January 1999.
The current directors of Recombigen Laboratories Private Limited are
The primary industry of Recombigen Laboratories Private Limited is Manufacturing.
Recombigen Laboratories Private Limited is unlisted.
The authorized capital of Recombigen Laboratories Private Limited is ₹1.25 Cr, and the paid-up capital is ₹5.11 M.
The compliance status of Recombigen Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX